Discontinuation report FORTAZ

Last updated on 2020-12-22 History
Report ID 130597
Drug Identification Number 02212226
Brand name FORTAZ
Common or Proper name Ceftazidime
Company Name GLAXOSMITHKLINE INC
Market Status DORMANT
Active Ingredient(s) CEFTAZIDIME
Strength(s) 2G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size All pack sizes / Tous les formats
ATC code J01DD
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2020-12-21
Remaining supply date 2018-05-31
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-12-22 English Compare
v2 2020-12-22 French Compare
v3 2020-12-22 English Compare
v4 2020-12-22 French Compare